Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This is a single-site, randomized, placebo-controlled, double blind phase 2b clinical trial. Patients with Thalassemia will participate in this study and will be treated with Denosumab or placebo. The effect of Denosumab on lumbar spine BMD in patients with Thalassemia Major and Osteoporosis will be evaluated as compared with control (placebo) at 12 months.
Critère d'inclusion
- Thalassemia major,Osteoporosis